AbbVie FY2025 EPS Estimate Decreased by Cantor Fitzgerald
AbbVie Inc. (NYSE:ABBV – Free Report) – Equities researchers at Cantor Fitzgerald lowered their FY2025 earnings per share (EPS) estimates for AbbVie in a research report issued on Wednesday, April 30th. Cantor Fitzgerald analyst C. Gould now anticipates that the company will post earnings per share of $12.31 for the year, down from their prior […]
AbbVie Inc. (NYSE:ABBV – Free Report) – Equities researchers at Cantor Fitzgerald lowered their FY2025 earnings per share (EPS) estimates for AbbVie in a research report issued on Wednesday, April 30th. Cantor Fitzgerald analyst C. Gould now anticipates that the company will post earnings per share of $12.31 for the year, down from their prior […]
